Background A strong association between obstructive sleep apnea (OSA) and the risk for
cardiovascular and cerebrovascular diseases has been reported. Continuous positive …

Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

Background Previous, largely uncontrolled studies demonstrated the substantial effects of
continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and …

Background Suboptimal CPAP adherence in OSA clinical trials involving predominantly
white men limits interpretability and generalizability. We examined predictors of CPAP …

Background and objective Although positive screening for and treatment of obstructive sleep
apnea (OSA) have been recommended for patients with cardiovascular problems, patient …

Background Obstructive sleep apnea syndrome (OSAS) has been associated with increased
morbidity and mortality, principally from cardiovascular disease, but the impact of nasal …

Rationale: Obstructive sleep apnea (OSA) is linked to increased cardiovascular risk, but the
impact of mild forms of OSA and their treatment on cardiovascular outcomes remains …

Obstructive sleep apnea (OSA) is a disorder which afflicts a large number of individuals
around the world. OSA causes sleepiness and is a major cardiovascular risk factor. Since its …

Rationale In obstructive sleep apnea patients (OSA), continuous positive airway pressure
(CPAP) adherence is crucial to improve symptoms and cardiometabolic outcomes. The …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …